6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: XTL BIOPHARMACEUTICALS LTD
Filed: May 31, 2011
Period of Report: May 31, 2011
Accession Number: 0001144204-11-033046

View Document ↗ View on SEC.gov ↗